Details

Autor(en) / Beteiligte

• Lapeyrere, Nadège
• Parrens, Marie
• Coindre, Jean-Michel
• Soubeyran, Isabelle
• de Mascarel, Antoine
• Merlio, Jean-Philippe
• Lebail, Brigitte
• Lepreux, Sébastien
• Jaffre, Anne
• Gilleron, Véronique
• Mathoulin-Pélissier, Simone
• Vergier, Béatrice

Titel

Impact of pathological review by an expert on the diagnosis and management of patients with cancer in Aquitania

Ist Teil von

• Annales de pathologie, 2008-12, Vol.28 (6), p.478-485

Ort / Verlag

France

Erscheinungsjahr

2008

Quelle

MEDLINE

Beschreibungen/Notizen

• The goal of this work was to evaluate the impact of expert pathological second opinion on the diagnosis and management of patients with cancer, in a French region (Aquitaine) and with an economic point of view. The study was first quantitative, performed retrospectively on all cases of cancer, voluntary sent for a second opinion to an expert pathologist of two centers. Secondly, we restricted the study to lymphoid, melanocytic and soft tissue tumors sent for second opinion. We considered that the expert review had an important diagnostic impact either when the initial pathologist sent the specimen to identify or classify malignant tumor or hesitated between benign and malignant tumor or had no hypothesis, or if there were discordant diagnoses (malignant/benign) between the two pathologists. We considered that the expert review had a high therapeutic impact if the disagreement between initial and expert diagnoses induced a complete modification in therapy. We evaluated the cost of second opinion for the expert centers and the cost of care management. Over the year 2006, the expert centers received 5077 lesions for consultation: 3769 specimens were sent by a pathologist for a second review, 1324 by pathologists of Aquitania and of these, 751 samples were submitted for lymphoid (55%), soft tissues (30%) or melanocytic tumors (15%). There was an important diagnostic impact for 75% of the samples; the impact of the expert review on patient management was considered high for 46% of specimens and the expert pathological diagnosis modified the clinical prognosis for 40% of the specimens. We estimated that for 53 discordant diagnoses (malignant/benign), second opinion allowed an economy of 500,000 euro. Expert second opinion is very important not only for diagnosis and management for patient with cancer but also for economic reasons.